to switch or not to switch: patient case discussions on integrating biosimilars in multiple scler...
Published 5 months ago • 8 plays • Length 29:22Download video MP4
Download video MP3
Similar videos
-
37:54
biosimilars in multiple sclerosis: entering a new era of biologic therapy
-
37:52
biosimilars 101: from neurologists, for neurologists
-
18:23
biosimilars for ibd: to start, switch, or stay away?
-
59:07
hear from the experts: generic and biosimilar therapies for ms treatment
-
53:30
switching to biosimilars: a conversation with peter taylor
-
20:47
biosimilars for ibd: start, switch, or stay away?
-
5:14
effectiveness of generic and biosimilar medications
-
2:41
switching to biosimilars 2021
-
25:11
biosimilars - switching & "interchangeable"
-
45:46
ben thrower, md: brand vs. generics vs. biosimilars vs. bioequivalence: january 2023
-
2:46
switching to biosimilars.
-
22:06
ms wellness summit - a discussion on biosimilars - what are they?
-
4:47
biosimilar ms medications | what to expect
-
57:11
generics and biosimilars: sorting out fact from fiction
-
4:21
biosimilars - making the switch
-
1:54
biosimilars are alternatives for original antibodies
-
![[on-demand webinar] the biosimilar market: an evolving landscape in ms research](https://i.ytimg.com/vi/MvQO2FomiBs/mqdefault.jpg)
57:50
[on-demand webinar] the biosimilar market: an evolving landscape in ms research
-
12:13
what is a multiple sclerosis pseudo-exacerbation?
-
2:13
safety and efficacy of biosimilars and generics